Vers une nouvelle définition de la maladie d’Alzheimer

McKhann, 1984, Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 Varma, 1999, Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and fronto temporal dementia, J. Neurol. Neurosurg Psychiatry, 66, 184, 10.1136/jnnp.66.2.184 Petersen, 1999, Mild cognitive impairment: Clinical characterization and outcome, Arch. Neurol., 56, 303, 10.1001/archneur.56.3.303 Morris, 2009, Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease, Arch. Neurol., 66, 1469, 10.1001/archneurol.2009.269 Dubois, 2007, Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria, Lancet Neurol., 6, 734, 10.1016/S1474-4422(07)70178-3 Hauw, 2000, Neuropathologie de la maladie d’Alzheimer, Ann Pathol., 20, 448 Sarazin, 2007, Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study, Neurology, 69, 1859, 10.1212/01.wnl.0000279336.36610.f7 Dubois, 2004, Amnestic MCI or prodromal Alzheimer’s disease?, Lancet Neurol., 3, 246, 10.1016/S1474-4422(04)00710-0 Lehericy, 1994, Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease, Am. J. Neuroradiol., 15, 929 Chupin, 2007, Anatomically constrained region deformation for the automated segmentation of the hippocampus and the amygdala: Method and validation on controls and patients with Alzheimer’s disease, Neuroimage, 34, 996, 10.1016/j.neuroimage.2006.10.035 Colliot, 2008, Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus, Radiology, 248, 194, 10.1148/radiol.2481070876 Magnin B., Mesrob L., Kinkingnehun S., et al. Support vector machine-based classification of Alzheimer’s disease from whole-brain anatomical MRI. Neuroradiology, Feb, 51(2), 73-83. Gerardin, 2009, Multidimensional classification of hippocampal shape features discriminates Alzheimer’s disease and mild cognitive impairment from normal aging, Neuroimage, 47, 1746, 10.1016/j.neuroimage.2009.05.036 Patwardhan, 2004, Alzheimer disease: operating characteristics of PET-a meta-analysis, Radiology, 231, 73, 10.1148/radiol.2311021620 Habert, 2011, Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer’s disease among patients with mild cognitive impairment, Neurobiol. Aging, 32, 15, 10.1016/j.neurobiolaging.2009.01.013 Clark, 2012, Cerebral PET with Florbetapir compared with neuropathology at autopsy: a prospective cohort study, Lancet Neurol., 11, 669, 10.1016/S1474-4422(12)70142-4 Koivunen, 2011, Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study, Neurology, 76, 1085, 10.1212/WNL.0b013e318212015e Blennow, 2010, Cerebrospinal fluid and plasma biomarkers in Alzheimer disease, Nat. Rev. Neurol., 6, 131, 10.1038/nrneurol.2010.4 De Souza, 2012, CSF tau markers are correlated with hippocampal volume in Alzheimer’s disease, Neurobiol. Aging, 33, 1253, 10.1016/j.neurobiolaging.2011.02.022 De Souza, 2011, Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer’s disease from other cortical dementias, J. Neurol. Neuro-surg. Psychiatry, 82, 240, 10.1136/jnnp.2010.207183 Hansson, 2006, Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study, Lancet Neurol., 5, 228, 10.1016/S1474-4422(06)70355-6 Dubois, 2010, Revising the definition of Alzheimer’s disease: a new lexicon, Lancet Neurol., 9, 1118, 10.1016/S1474-4422(10)70223-4 Tapiola, 2009, Cerebrospinal fluid {beta} - amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain, Arch Neurol., 66, 382, 10.1001/archneurol.2008.596 Bouwman, 2010, New research criteria for the diagnosis of Alzheimer’s disease applied in a memory clinic population, Dement. Geriatr. Cogn. Disord., 30, 1, 10.1159/000315542 Albert, 2011, The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, Alzheimers Dement., 7, 270, 10.1016/j.jalz.2011.03.008